Skip to main content
Fig. 6 | Journal of Translational Medicine

Fig. 6

From: Personalizing the safe, appropriate and effective concentration(s) of ozone for a non-diabetic individual and four type II diabetic patients in autohemotherapy through blood hemoglobin analysis

Fig. 6

UV–VIS absorption spectral changes related to the peptide and aromatic residue bands. a UV–VIS spectra of oxy-Hb for the non-diabetic individual A. b–e UV–VIS spectra of oxy-Hb for the diabetic patients B to E, respectively. The peaks are related to the 222 nm peptide band and 278 nm aromatic residues band

Back to article page